Medinotec Inc. MDNC
OTC PK
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.90% | 2.18% | 6.38% | 45.24% | 56.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.90% | 2.18% | 6.38% | 45.24% | 56.80% |
| Cost of Revenue | -0.71% | -2.90% | 7.04% | 9.48% | 28.18% |
| Gross Profit | -19.31% | 7.02% | 5.78% | 91.17% | 92.17% |
| SG&A Expenses | 53.67% | 146.13% | 157.99% | 73.07% | 40.32% |
| Depreciation & Amortization | 112.06% | 49.37% | 9.62% | -52.56% | -32.81% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.78% | 35.44% | 45.01% | 26.92% | 33.89% |
| Operating Income | -79.59% | -68.81% | -65.70% | 124.41% | 172.37% |
| Income Before Tax | -79.46% | -66.97% | -64.64% | 153.63% | 750.48% |
| Income Tax Expenses | -93.59% | -87.35% | -68.23% | 82.50% | 140.04% |
| Earnings from Continuing Operations | -73.44% | -58.71% | -63.21% | 199.82% | 10,364.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.44% | -58.71% | -63.21% | 199.82% | 10,364.38% |
| EBIT | -79.59% | -68.81% | -65.70% | 124.41% | 172.37% |
| EBITDA | -76.57% | -66.47% | -64.01% | 110.59% | 154.82% |
| EPS Basic | -75.33% | -59.12% | -63.90% | 170.78% | 9,805.26% |
| Normalized Basic EPS | -82.46% | -69.05% | -66.75% | 115.54% | 202.39% |
| EPS Diluted | -75.33% | -59.12% | -63.90% | 170.78% | 9,805.26% |
| Normalized Diluted EPS | -82.46% | -69.05% | -66.75% | 115.54% | 202.39% |
| Average Basic Shares Outstanding | 0.67% | -4.43% | -4.48% | 9.34% | -1.73% |
| Average Diluted Shares Outstanding | 0.67% | -4.43% | -4.48% | 9.34% | -1.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |